Showing results (21-30 of 306) with videos related to
Sort By:
Pageof 31
International Journal of Molecular Sciences|September 28, 2021
A Computational Workflow for the Identification of Novel Fragments Acting as Inhibitors of the Activity of Protein Kinase CK1δGiovanni Bolcato, Eleonora Cescon, Matteo Pavan, et al.Chemmedchem|April 28, 2023
Are Two Riboses Better Than One? The Case of the Recognition and Activation of Adenosine ReceptorsTeresa Gianferrara, Matteo Pavan, Davide Bassani, et al.Acta Crystallographica. Section D, Structural Biology|March 2, 2022
A new inactive conformation of SARS-CoV-2 main proteaseEmanuele Fornasier, Maria Ludovica Macchia, Gabriele Giachin, et al.European Journal of Medicinal Chemistry|January 29, 2023
1,2,4-Amino-triazine derivatives as pyruvate dehydrogenase kinase inhibitors: Synthesis and pharmacological evaluationCamilla Pecoraro, Michele De Franco, Daniela Carbone, et al.International Journal of Molecular Sciences|February 25, 2023
Discovery of the 3-Amino-1,2,4-triazine-Based Library as Selective PDK1 Inhibitors with Therapeutic Potential in Highly Aggressive Pancreatic Ductal AdenocarcinomaDaniela Carbone, Michele De Franco, Camilla Pecoraro, et al.Future Medicinal Chemistry|April 1, 2017
Estimation of kinetic and thermodynamic ligand-binding parameters using computational strategiesGiuseppe Deganutti, Stefano MoroExpert Opinion on Therapeutic Patents|May 16, 2009
Novel camptothecin derivatives as topoisomerase I inhibitorsSerena Basili, Stefano MoroMolecules (Basel, Switzerland)|May 13, 2023
Past, Present, and Future Perspectives on Computer-Aided Drug Design MethodologiesDavide Bassani, Stefano MoroMolecules (Basel, Switzerland)|May 17, 2017
Supporting the Identification of Novel Fragment-Based Positive Allosteric Modulators Using a Supervised Molecular Dynamics Approach: A Retrospective Analysis Considering the Human A2A Adenosine Receptor as a Key ExampleGiuseppe Deganutti, Stefano MoroPageof 31